Adjusted Regressions Predicting Undiagnosed Diabetes or Impaired Fasting Glucose or Undiagnosed Diabetes Alone Using Hepatitis B Core Antibody, Hepatitis C Antibody (Confirmed), and Liver Enzymes*
| Undiagnosed Impaired Fasting Glucose | Undiagnosed Diabetes | |
|---|---|---|
| Hepatitis B core antibody | ||
| Positive | 0.98 (0.64–1.52) | 1.42 (0.63–3.24) |
| Negative | 1.00 (—) | 1.00 (—) |
| Hepatitis C core antibody (confirmed) | ||
| Positive | 1.12 (0.55–2.25) | 2.23 (0.44–11.20) |
| Negative | 1.00 (—) | 1.00 (—) |
| ALT | ||
| Low | 1.00 (—) | 1.00 (—) |
| High | 1.44 (1.15–1.79) | 1.84 (1.06–3.20) |
| AST | ||
| Low | 1.00 (—) | 1.00 (—) |
| High | 1.12 (0.95–1.34) | 0.78 (0.44–1.37) |
| GGT | ||
| Low | 1.00 (—) | 1.00 (—) |
| High | 1.23 (1.00–1.53) | 2.15 (1.44–3.20) |
* Adjusted for age, gender, race/ethnicity, body mass index, high cholesterol and hypertension. All data provided as odds ratio (95% CI).
ALT, alanine aminotransferase; AST, aspartate aminotransferase; GGT, γglutamyl transferase.